Emy key facts
as of Oct 2026- Developer of medical devices designed to provide perineal rehabilitation for women.
- Emy is valued at approximately $15.4M as of Oct 2026 (last reported valuation).
- It has raised $6.3M; the latest was Later Stage VC ($4.2M) in Mar 2025.
- Notable investors include Bpifrance, UI Investissement, Capital Grand Est, 28DIGITAL, Alsace Business Angels — 15 tracked in total.
- Status: Privately Held (backing).
Emy's last reported valuation, Mar 2025. Nothing priced has surfaced since.
- ·The complete investor list: 15 names
- ·Watch Emy: the Monday email on marks, rounds and moves
Emy funding rounds
No funding rounds for Emy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Emy
15+Emy valuation
Emy's last reported valuation was $15.4 million in Mar 2025. No priced round, secondary trade or fund mark has surfaced since.
Emy investors
15 investors are on record for Emy, including Bpifrance, UI Investissement, Capital Grand Est and 28DIGITAL.
About Emy
Developer of medical devices designed to provide perineal rehabilitation for women. The company's devices offer medical guidance through fun exercises to facilitate perineal re-education as to when and how to perform perineum strengthening exercises at home while remaining motivated, enabling women who suffer from urinary leakage to tackle urinary incontinence problems occurring after childbirth or throughout life.
- Sector
- Healthcare
- HQ
- Strasbourg, France
- Founded
- 2017
- Employees
- 26
- Website
- emy.fizimed.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.